[1] YOU S P,ZHAO J,MA L,et al. Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin induced hepatic fibrosis in rats[J]. Daru,2015,23:52. [2] 木克热木·吐地买提,由淑萍,赵军,等. 肉苁蓉苯乙醇苷类成分对BSA致大鼠肝纤维化影响的实验研究[J]. 新疆医科大学学报,2015,38(5):567-570. [3] 由淑萍,赵军,马龙,等. 肉苁蓉乙醇提取物抗大鼠免疫性肝纤维化的作用及其机制[J]. 中国药理学与毒理学杂志,2016,30(5):504-510. [4] YOU S P,ZHAO J,MA L,et al. Phenylethanol glycosides from cistanche tubulosa suppress hepatic stellate cell activation and block the conduction of signaling pathways in TGF-β1/smad as potential anti-hepatic fibrosis agents[J]. Molecules,2016,21(1):102. [5] 陈振,许君望,严肃,等. 重组人松弛素-2对肝星状细胞增殖、Ⅰ型胶原合成及TGF-β1与CTGF mRNA表达的影响[J]. 西安交通大学学报(医学版),2017,38(1):44-47,57. [6] FRIEDMAN S L. Hepatic stellate cells:Protean,multifunctional,and enigmatic cells of the liver[J]. Physiol Rev,2008,88(1):125-172. [7] 丁茜,李振,刘滨,等. 卡维地洛抑制血小板衍生因子BB诱导的人肝星状细胞活化和纤维化的作用机制[J]. 临床肝胆病杂志,2017,33(3):485-491. [8] JIAO J,FRIEDMAN S L,ALOMAN C. Hepatic fibrosis[J]. Curr Opin Gastroenterol,2009,25(3):223-229. [9] QU K,HUANG Z,LIN T,et al. New insight into the anti-liver fibrosis effect of multitargeted tyrosine kinase inhibitors:from molecular target to clinical trials[J]. Front Pharmacol,2016,6:300. [10] 张季,宋嬿,王巧晗,等. 生醋莪术对大鼠免疫性肝纤维化及HSC-T6增殖和α-SMA,ProcollagenⅠ表达的影响[J]. 中国中药杂志,2017,42(13):2538-2545. [11] 梁昊,代勇,孙雪英,等. 中医药针对肝星状细胞抗肝纤维化作用机制研究综述[J]. 云南中医中药杂志,2015,36(7):78-79. [12] 唐桂连. 肝星状细胞与肝纤维化[J]. 国际消化杂志,2012,10(5):270-272. [13] 郑艳华,王建彬. 肝星状细胞的凋亡与肝纤维化的研究进展[J]. 现代中西医结合杂志,2011,20(6):772-773. [14] 张琴,黄涛,卓强. 肝纤维化中MAPK信号转导通路对肝星状细胞活性的影响[J]. 成都医学院学报,2014,9(4):493-495. [15] 王一丹,韩涛,何金荣. 中药提取物治疗肝纤维化的研究进展综述[J]. 医学综述,2012,18(24):4228-4230. [16] CHEN P,LI J,HUO Y,et al. Orphan nuclear receptor NR4A2 inhibits hepatic stellate cell proliferation through MAPK pathway in liver fibrosis[J]. Peer J, 2015,3:e1518. [17] FANG L,ZHAN S,HUANG C,et al. TRPM7 channel regulates PDGF-BB induced proliferation of hepatic stellate cells via PI3K and ERK pathways[J]. Toxicol Appl Pharmacol,2013,272:713-725. |